These compounds may interact with:
Receptor tyrosine-protein kinase erbB-4
Potentially involved in: polycystic ovary syndrome; neurodegenerative disease; amyotrophic lateral sclerosis; lung cancer; endometrial cancer; breast cancer; melanoma; kidney cancer; carcinoma; liver cancer; skin cancer; rheumatoid arthritis; schizophrenia; cancer; anxiety; bipolar disorder; depressive disorder; dyspnea; fatigue; gallbladder neoplasm
Disease data sourced from Pharos.